Mori K - Search Results

1

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.

Miwa M, Ura M, Nishida M, Sawada N, Ishikawa T, Mori K, Shimma N, Umeda I, Ishitsuka H. Miwa M, et al. Among authors: mori k. Eur J Cancer. 1998 Jul;34(8):1274-81. doi: 10.1016/s0959-8049(98)00058-6. Eur J Cancer. 1998. PMID: 9849491

2

Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues.

Nishida M, Hino A, Mori K, Matsumoto T, Yoshikubo T, Ishitsuka H. Nishida M, et al. Among authors: mori k. Biol Pharm Bull. 1996 Nov;19(11):1407-11. doi: 10.1248/bpb.19.1407. Biol Pharm Bull. 1996. PMID: 8951154 Free article.

3

Enhancement of capecitabine efficacy by oxaliplatin in human colorectal and gastric cancer xenografts.

Sawada N, Kondoh K, Mori K. Sawada N, et al. Among authors: mori k. Oncol Rep. 2007 Oct;18(4):775-8. Oncol Rep. 2007. PMID: 17786335

4

Murine interleukin-12 prevents the development of cancer cachexia in a murine model.

Mori K, Fujimoto-Ouchi K, Ishikawa T, Sekiguchi F, Ishitsuka H, Tanaka Y. Mori K, et al. Int J Cancer. 1996 Sep 17;67(6):849-55. doi: 10.1002/(SICI)1097-0215(19960917)67:6<849::AID-IJC15>3.0.CO;2-X. Int J Cancer. 1996. PMID: 8824558

5

Establishment and characterization of cachexia-inducing and -non-inducing clones of murine colon 26 carcinoma.

Fujimoto-Ouchi K, Tamura S, Mori K, Tanaka Y, Ishitsuka H. Fujimoto-Ouchi K, et al. Among authors: mori k. Int J Cancer. 1995 May 16;61(4):522-8. doi: 10.1002/ijc.2910610416. Int J Cancer. 1995. PMID: 7759158

6

[Antitumor activity of various cytostatics in mice bearing murine advanced tumors].

Fujimoto-Ouchi K, Tamura S, Mori K, Ishikawa T, Eda H, Tanaka Y, Ninomiya Y, Ishitsuka H. Fujimoto-Ouchi K, et al. Among authors: mori k. Gan To Kagaku Ryoho. 1993 Dec;20(15):2361-7. Gan To Kagaku Ryoho. 1993. PMID: 8259852 Japanese.

7

Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues.

Mori K, Hasegawa M, Nishida M, Toma H, Fukuda M, Kubota T, Nagasue N, Yamana H, Hirakawa-YS Chung K, Ikeda T, Takasaki K, Oka M, Kameyama M, Toi M, Fujii H, Kitamura M, Murai M, Sasaki H, Ozono S, Makuuchi H, Shimada Y, Onishi Y, Aoyagi S, Mizutani K, Ogawa M, Nakao A, Kinoshita H, Tono T, Imamoto H, Nakashima Y, Manabe T. Mori K, et al. Int J Oncol. 2000 Jul;17(1):33-8. doi: 10.3892/ijo.17.1.33. Int J Oncol. 2000. PMID: 10853015

8

Antitumor activity of chemoendocrine therapy in premenopausal and postmenopausal models with human breast cancer xenografts.

Kataoka M, Yamaguchi Y, Moriya Y, Sawada N, Yasuno H, Kondoh K, Evans DB, Mori K, Hayashi S. Kataoka M, et al. Among authors: mori k. Oncol Rep. 2012 Feb;27(2):303-10. doi: 10.3892/or.2011.1541. Epub 2011 Nov 9. Oncol Rep. 2012. PMID: 22076074

9

Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft.

Tamura S, Ouchi KF, Mori K, Endo M, Matsumoto T, Eda H, Tanaka Y, Ishitsuka H, Tokita H, Yamaguchi K. Tamura S, et al. Among authors: mori k. Clin Cancer Res. 1995 Nov;1(11):1353-8. Clin Cancer Res. 1995. PMID: 9815931

10

Antitumor activity of bevacizumab in combination with capecitabine and oxaliplatin in human colorectal cancer xenograft models.

Yanagisawa M, Fujimoto-Ouchi K, Yorozu K, Yamashita Y, Mori K. Yanagisawa M, et al. Among authors: mori k. Oncol Rep. 2009 Aug;22(2):241-7. Oncol Rep. 2009. PMID: 19578762

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,615 results

Search Page

Filters